Financials
Financial year 2025
L2Be Pharma from Binche, company number BE0764501936, closed financial year 2025 with a result of € 14,987 after tax. For that financial year L2Be Pharma recorded a gross margin of € 36,781 and equity of € 57,221. Compared with financial year 2024, the result moved from € 22,063 to € 14,987. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 57,221
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 14,987
▼ 32% vs 2024
Profit after tax over the fiscal year.
€ 123,358
▲ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 14,987 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,016
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,720
▼ 29% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 11,670 | € 57,436 | € 32,550 | € 36,781 | ▲ 13% |
| Profit after taxes | € 5,421 | € 42,897 | € 22,063 | € 14,987 | ▼ 32% |
| Equity | € 57,221 | € 100,117 | € 57,221 | € 57,221 | |
| Total debts | € 35,520 | € 40,223 | € 90,728 | € 96,349 | ▲ 6% |
| Cash | € 62,926 | € 90,710 | € 100,973 | € 123,358 | ▲ 22% |
| Retained profit | € 52,221 | € 95,117 | € 52,221 | € 52,221 | |
| Dividend | € 0 | € 0 | € 65,294 | € 14,987 | ▼ 77% |
| Balance sheet total | € 92,741 | € 140,340 | € 147,948 | € 153,570 | ▲ 4% |
Key figures of L2Be Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to L2Be Pharma?
What happened at L2Be Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 14,987 (▼ 32% vs 2024). Source: NBB ↗
- New establishment in Binche. KBO
- LEILA BOUDAKA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 5,421 profit in 2022 to € 14,987 profit in 2025.
Paid € 26,863 in corporate taxes since 2022.
Best year ever: 2023, with € 42,897 profit.
Paid out € 80,281 in dividends to the owners in total.
A new publication or filing at L2Be Pharma? We notify you, reason included.
Follow L2Be PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
LEILA BOUDAKA
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Rue Saint-Paul(BIN) 47
7130 Binche
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Hostinger Mail
Hosting
AS-HOSTINGER, CY
Website info
Features
Security
Network
Details
- Company number
- 0764.501.936
- VAT number
- BE 0764.501.936
- Registered office
- Rue Saint-Paul(BIN) 47, 7130 Binche
- Names & denominations
- L2Be Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 March 2021
- Peppol
- Active · Active since 20 Jun 2025
- Contact
- pharmacievanlautem-andre.be
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Beroepsopleiding
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering